The Hsinchu Science Park 42nd Anniversary Gala Dinner, with the theme titled "Innovation as the Driving Force, Sustainability as the Focal Point," took place...
Sesen Bio, Inc. and Carisma Therapeutics Inc., a privately-held, clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced an amendment to...
EnfraGen, LLC, a developer, owner, and operator of specialized sustainable, renewable power and grid stability assets in Latin America owned by Glenfarne Energy Transition,...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the initiation of a Phase 2 trial...
